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Abstract
A patient with mitral stenosis and multiple left atrial thrombi underwent valvuloplasty and thrombectomy. While
closing the sternum after completing the cardiopulmonary bypass, a new left atrial thrombus was detected by
transesophageal echocardiography. We used heparin for the prevention of new thrombus formation and closed
the wound after meticulous bleeding control. Three months later, there was no residual thrombus in the left
atrium according to the echocardiographic study.
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Background
Acute left atrial thrombosis immediately after cardiopul-
monary bypass is rare, but it is a serious and sometimes
fatal complication during cardiac surgery [1,2]. The fac-
tors associates with acute thrombosis during cardiac
surgery include the use of aprotinin, a long pump time,
the use of heparin and protamine, and transfusion of
blood components. The other factors associates with
acute thrombosis include congenital antithrombin III
deficiency, acquired protein C and protein S deficiency,
antiphospholipid antibody syndrome and hyperhomocys-
teinemia [3-5]. Each of these factors may cause this
complication by itself or by acting in combination [6,7].
We report a case of new left atrial thrombus forma-
tion immediately after cardiopulmonary bypass in
patient with mitral valvuloplasty and left atrial
thrombectomy.
Case presentation
A 72 years old male patient was hospitalized after a
month of heart palpitations. One month previously, the
patient complained of slight chest discomfort and palpi-
tations while climbing stairs. The patient received medi-
c a t i o n sa tt h a tt i m e ,b u tt h e yd i dn o th e l pr e l i e v et h e
symptoms. The patient had been previously diagnosed
with atrial fibrillation 15 years ago, and he had not been
treated for it with any medication, including
anticoagulants.
On admission to the hospital, a mid-diastolic rumbling
murmur was heard (Grade III/VI) at the apex of the
chest on the physical examination. A standard chest PA
showed an increase of the pulmonary vascular markings
and enlargement of the left atrium. The echocardiogra-
phy showed a mitral valve orifice of 0.83 cm
2, a mean
diastolic pressure gradient of 10 mmHg and a left atrial
volume index of 96 mm
3/m
2. In addition, there were tri-
vial amounts of mitral regurgitation and multiple vari-
ably sized thrombi, including an 8 × 5 cm thrombus, in
the septum, posterior wall and entrance of the left
auricle.
Surgery was performed under general anesthesia with
superior and inferior vena cava and aortic cannulation.
After the procedure, antegrade and retrograde cold
blood cardioplegia was used for myocardial protection.
The left atrium was opened through the Waterston’s
groove to remove the multiple thrombi; however, the
atrial surface was very rough even after removing the
thrombi (Figure 1). Resection of the left atrial auricle,
mitral valvuloplasty and partial left atrial volume reduc-
tion were performed. During the cardiopulmonary
bypass, the ACT remained greater than 450 seconds and
there was no problem during weaning from the
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the ACT was 130 seconds. The platelet count was
45,000/mm
3 during sternal closure; five units of platelets
were then transfused. After this, no mitral regurgitation
was observed by trans-esophageal echocardiogram, but a
new thrombus was detected at the left atrium (Figure 2).
Injection of 0.5 mg of heparin/kg was done to maintain
the ACT at greater than 250 seconds and to block the
formation of new thrombi. The developing thrombus
did not affect the blood flow through the mitral valve;
the sternum was closed and the surgery completed.
On that day, the patient received constant doses of
heparin until postoperative day 1, and then the medica-
tion was changed to Coumadin for further anticoagula-
tion. To determine the cause of thrombus formation,
coagulation studies such as hyperhomocysteinemia and
heparin-induced thrombocytopenia were performed
using a blood sample from surgery. Yet we could not
find a definite cause of the new thrombus formation on
the hematologic studies. The patient gradually recovered
with no special problems. The postoperative echocardio-
gram on day 10 showed a mitral valve area of 1.77 cm
2
and a mean diastolic pressure gradient of 5.1 mmHg.
While some signs of thrombus formation at the left
atrium were noted during early follow-up, by three
months post-surgery none were detected on the follow
up echocardiogram (Figure 2).
Discussion
There were many possible factors which cause throm-
bosis after cardiopulmonary bypass. As a surgical fac-
tors, the use of aprotinin, a long pump time, the use of
Figure 1 A) Large thrombus in the left atrium. B) The surface of the left atrium was very rough even after the removal of thrombi.
Figure 2 A) Transesophageal echocardiogram shows new thrombus formation in the left atrium (arrow). B) Left atrial thrombus was not
seen in transthoracic echocardiogram (postoperative 3 months). LA: left atrium; LV: left ventricle.
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components. The other factors associates with acute
thrombosis include congenital antithrombin III defi-
ciency, acquired protein C and protein S deficiency,
antiphospholipid antibody syndrome and hyperhomo-
cysteinemia [3-5]. Each of these factors may cause this
complication by itself or by acting in combination
[6,7].
Our patient was negative for antithrombin III defi-
ciency and hyperhomocysteinemia. The protein C anti-
gen and protein S antigen were decreased on the
antiphospholipid antibody study. But the use of
heparin for cardiopulmonary bypass might have
affected these antigen levels. The use of heparin might
have also contributed to the sudden development of
acute thrombus formation. The study for heparin-
induced thrombocytopenia was negative. We did not
use aprotinin. The cardiopulmonary bypass time was
114 minutes and this was no longer than for the usual
mitral valve operation. Besides the hematologic rea-
sons, the factors associated with thrombus formation
are a large atrial volume and insufficient relief of
mitral stenosis. However, in this case, the postoperative
area of the mitral valve orifice was 1.77 m
2,w h i c hd i d
not affect blood flow. Another possibility is that curet-
tage of the left atrium for the multiple thrombi left its
large surface very rough, and this might have pro-
moted additional thrombus formation. In addition, the
platelet transfusion during surgery might have contrib-
uted to the development of an acute thrombus. The
thrombus was detected by intraoperative transesopha-
geal echocardiography and this procedure was essential
for making an early diagnosis.
For management, we thought that if cardiopulmonary
bypass was restarted, the opening of the left atrium to
remove the thrombus might have increased the risk for
repeat thrombus formation during heparin reversal.
Injecting thrombolytic agents has a significant risk for
bleeding. We decided to solve this problem with injec-
tion of low dose heparin for maintaining the ACT at
greater than 250 seconds for prevention of new throm-
bus formation.
Conclusions
In patient with acute new left atrial thrombus formation
immediately after cardiopulmonary bypass, the possible
management is to inject anticoagulants with close obser-
vation to prevent further formation of thrombus, if the
blood flow through the mitral valve isn’t affected and
there are no signs of bleeding.
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